In a case report of a 78-year-old patient treated with anti-CD19 CAR T cell for CLL, the patient had an incidental TET-2 (c.5635C mutation) and shows disease control and CAR T cell detection 4.2 years after treatment [240]. The gene discussed is TET2; the disease is B-cell chronic lymphocytic leukemia.